Predictors of Inadequate Response and Rapid Radiographic Progression in Patients with Early Rheumatoid Arthritis Receiving Methotrexate: a Post Hoc Analysis of 2 Randomized, Controlled Trials of Adalimumab

被引：0
|
作者：
Kavanaugh, Arthur [1 ]
van Vollenhoven, Ronald F. [2 ]
Wolfe, Benjamin A. [3 ]
Florentinus, Stefan [3 ]
Chen, Su [3 ]
Suboticki, Jessica L. [3 ]
Smolen, Josef S. [4 ]
机构：
[1] Univ Calif San Diego, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA
[2] Amsterdam Rheumatol & Immunol Ctr ARC, Amsterdam, Netherlands
[3] AbbVie Inc, N Chicago, IL USA
[4] Med Univ Vienna, Vienna, Austria
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2651
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PREDICTORS OF INADEQUATE RESPONSE AND RAPID RADIOGRAPHIC PROGRESSION IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS RECEIVING METHOTREXATE: A POST HOC ANALYSIS OF 2 RANDOMIZED, CONTROLLED TRIALS OF ADALIMUMAB
    Kavanaugh, A.
    van Vollenhoven, R. F.
    Wolfe, B. A.
    Florentinus, S.
    Chen, S.
    Suboticki, J. L.
    Smolen, J. S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 822 - 823
  • [2] Predictors of Clinical Response and Radiographic Progression in Patients with Rheumatoid Arthritis Treated with Methotrexate Monotherapy
    Drouin, Julie
    Haraoui, Boulos
    [J]. JOURNAL OF RHEUMATOLOGY, 2010, 37 (07) : 1405 - 1410
  • [3] Methotrexate Safety and Efficacy in Combination Therapies in Patients With Early Rheumatoid Arthritis: A Post Hoc Analysis of a Randomized Controlled Trial
    Lend, Kristina
    Koopman, Frieda A.
    Lampa, Jon
    Jansen, Gerrit
    Hetland, Merete L.
    Uhlig, Till
    Nordstroem, Dan
    Nurmohamed, Michael
    Gudbjornsson, Bjorn
    Rudin, Anna
    Ostergaard, Mikkel
    Heiberg, Marte S.
    Sokka-Isler, Tuulikki
    Horslev-Petersen, Kim
    Haavardsholm, Espen A.
    Grondal, Gerdur
    Twisk, Jos W. R.
    van Vollenhoven, Ronald
    [J]. ARTHRITIS & RHEUMATOLOGY, 2024, 76 (03) : 363 - 376
  • [4] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Stephanie F. Ling
    Nisha Nair
    Suzanne M. M. Verstappen
    Anne Barton
    Hans-Dieter Zucht
    Petra Budde
    Peter Schulz-Knappe
    Darren Plant
    [J]. The Pharmacogenomics Journal, 2020, 20 : 516 - 523
  • [5] Proteomic analysis to define predictors of treatment response to adalimumab or methotrexate in rheumatoid arthritis patients
    Ling, Stephanie F.
    Nair, Nisha
    Verstappen, Suzanne M. M.
    Barton, Anne
    Zucht, Hans-Dieter
    Budde, Petra
    Schulz-Knappe, Peter
    Plant, Darren
    [J]. PHARMACOGENOMICS JOURNAL, 2020, 20 (03): : 516 - 523
  • [6] Less Radiographic Progression with Adalimumab Plus Methotrexate Versus Methotrexate Monotherapy Across the Spectrum of Clinical Response in Early Rheumatoid Arthritis
    Emery, Paul
    Genovese, Mark C.
    van Vollenhoven, Ronald
    Sharp, John T.
    Patra, Kaushik
    Sasso, Eric H.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (07) : 1429 - 1441
  • [7] Disease Activity Measures at Baseline and 3 Months as Predictors of Rapid Radiographic Progression in Methotrexate Naive Patients with Early Rheumatoid Arthritis
    Movahedi, Mohammad
    Weber, Deborah
    Akhavan, Pooneh
    Keystone, Edward
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [8] Predictors of disease activity and structural progression after treatment with adalimumab plus methotrexate or continued methotrexate monotherapy in patients with early rheumatoid arthritis and suboptimal response to methotrexate
    Smolen, Josef S.
    van Vollenhoven, Ronald F.
    Florentinus, Stefan
    Chen, Su
    Suboticki, Jessica L.
    Kavanaugh, Arthur
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (11) : 1566 - 1572
  • [9] Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials
    Tanaka, Yoshiya
    Atsumi, Tatsuya
    Aletaha, Daniel
    Bartok, Beatrix
    Pechonkina, Alena
    Han, Ling
    Emoto, Kahaku
    Kano, Shungo
    Rajendran, Vijay
    Takeuchi, Tsutomu
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (01) : 161 - 185
  • [10] Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials
    Yoshiya Tanaka
    Tatsuya Atsumi
    Daniel Aletaha
    Beatrix Bartok
    Alena Pechonkina
    Ling Han
    Kahaku Emoto
    Shungo Kano
    Vijay Rajendran
    Tsutomu Takeuchi
    [J]. Rheumatology and Therapy, 2023, 10 : 161 - 185
12345